{"transactions":[{"id":824342,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-31T20:09:14.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":false,"shares":3166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":3167,"derivative":{"underlying":"Common Stock","underlying_shares":3166},"source":{"system":"sec-edgar","filing":"0002013869-26-000002","document":"form4-03312026_080309.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000201386926000002/form4-03312026_080309.xml","form_type":"4"}},{"id":824341,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-31T20:09:14.000Z","date":"2026-03-28","kind":"exercise","planned":false,"acquired":true,"shares":3166,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":3166,"source":{"system":"sec-edgar","filing":"0002013869-26-000002","document":"form4-03312026_080309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000201386926000002/form4-03312026_080309.xml","form_type":"4"}},{"id":998029,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-17T21:05:46.000Z","date":"2025-11-14","kind":"exercise","planned":false,"acquired":false,"shares":8200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests 1/3 on March 28, 2025, March 28, 2026 and March 28, 2027, subject to the Eligible Director's continued service on such vesting date."}],"balance_after":16400,"derivative":{"exercise_price":9.88,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":8200},"source":{"system":"sec-edgar","filing":"0002013869-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000201386925000002/primary_doc.xml","form_type":"4"}},{"id":998028,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-17T21:05:46.000Z","date":"2025-11-14","kind":"sale","planned":false,"acquired":false,"shares":8200,"price":14.3474,"value":117648.68,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities were sold in multiple transactions at prices ranging from $14.02 to $14.60.  The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0002013869-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000201386925000002/primary_doc.xml","form_type":"4"}},{"id":998027,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-17T21:05:46.000Z","date":"2025-11-14","kind":"exercise","planned":false,"acquired":true,"shares":8200,"price":9.88,"value":81016.0,"ownership":{"direct":true},"balance_after":8200,"source":{"system":"sec-edgar","filing":"0002013869-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000201386925000002/primary_doc.xml","form_type":"4"}},{"id":998026,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-17T21:05:46.000Z","date":"2025-11-14","kind":"sale","planned":false,"acquired":false,"shares":3167,"price":14.3,"value":45288.1,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0002013869-25-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000201386925000002/primary_doc.xml","form_type":"4"}},{"id":1106602,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-18T20:35:44.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":20100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests 100% on the first anniversary of the date of grant, subject to the Eligible Director's continued service on such vesting date."}],"balance_after":20100,"derivative":{"exercise_price":4.47,"expiration_date":"2035-06-17","underlying":"Common Stock","underlying_shares":20100},"source":{"system":"sec-edgar","filing":"0001578563-25-000323","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000157856325000323/primary_doc.xml","form_type":"4"}},{"id":1186720,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-04-01T20:55:44.000Z","date":"2025-03-28","kind":"exercise","planned":false,"acquired":false,"shares":3167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 13, 2024, the Reporting Person was granted 9,500 restricted stock units, vesting 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":6333,"derivative":{"underlying":"Common Stock","underlying_shares":3167},"source":{"system":"sec-edgar","filing":"0001578563-25-000203","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000157856325000203/primary_doc.xml","form_type":"4"}},{"id":1186719,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-01T20:55:44.000Z","date":"2025-03-28","kind":"exercise","planned":false,"acquired":true,"shares":3167,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":3167,"source":{"system":"sec-edgar","filing":"0001578563-25-000203","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000157856325000203/primary_doc.xml","form_type":"4"}},{"id":1433978,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-08-14T21:04:51.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock upon the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":9500,"derivative":{"underlying":"Common Stock","underlying_shares":9500},"source":{"system":"sec-edgar","filing":"0001578563-24-000370","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000157856324000370/primary_doc.xml","form_type":"4"}},{"id":1433977,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":55106,"kind":"person","name":"Goldman Jonathan","position":1,"cik":"0002013869","reported_name":"Goldman Jonathan","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-14T21:04:51.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":24600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests 1/3 on March 28, 2025, March 28, 2026, and March 28, 2027, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":24600,"derivative":{"exercise_price":9.88,"expiration_date":"2034-08-13","underlying":"Common Stock","underlying_shares":24600},"source":{"system":"sec-edgar","filing":"0001578563-24-000370","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2013869/000157856324000370/primary_doc.xml","form_type":"4"}}]}